Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.

Multidrug resistance protein (MRP) 4 is a member of the MRP/ABCC subfamily of ATP-binding cassette transporters, which are capable of pumping a wide variety of endogenous and xenobiotic organic anionic compounds out of the cell. In addition to its role in the body distribution and renal excretion of a wide variety of antiviral, cytostatic, antibiotic and cardiovascular drugs, MRP4/ABCC4 has the remarkable ability to transport molecules involved in cellular signalling. These molecules include cyclic nucleotides, eicosanoids, urate and conjugated steroids. The unique structure, regulation and dual localisation of MRP4 in polarised cells could be connected with a key function in cellular protection and extracellular signalling pathways. This review focuses on recent insights into the versatile transport function of MRP4 and its potential as a new therapeutic target to modulate various pathophysiological signalling processes.

[1]  D. Keppler,et al.  Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. , 2005, The Journal of urology.

[2]  Yuichi Sugiyama,et al.  Evaluation of the Role of Breast Cancer Resistance Protein (BCRP/ABCG2) and Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in The Urinary Excretion of Sulfate and Glucuronide Metabolites of Edaravone (MCI-186; 3-Methyl-1-phenyl-2-pyrazolin-5-one) , 2007, Drug Metabolism and Disposition.

[3]  X. Chu,et al.  Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) , 2006, Journal of Pharmacology and Experimental Therapeutics.

[4]  L. Frati,et al.  Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Wijnholds,et al.  Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells* , 2003, The Journal of Biological Chemistry.

[6]  D. Keppler,et al.  Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain , 2004, Neuroscience.

[7]  P. Wielinga,et al.  Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). , 2003, The Biochemical journal.

[8]  H. Kusuhara,et al.  Involvement of MRP4 (ABCC4) in the Luminal Efflux of Ceftizoxime and Cefazolin in the Kidney , 2007, Molecular Pharmacology.

[9]  Jatinder Lamba,et al.  Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450* , 2001, The Journal of Biological Chemistry.

[10]  F. Russel,et al.  Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia , 2007, Pflügers Archiv - European Journal of Physiology.

[11]  G. Kruh,et al.  Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice , 2007, Cancer and Metastasis Reviews.

[12]  J. Wijnholds,et al.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Wielinga,et al.  Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy , 2004, Molecular and Cellular Biology.

[14]  J. Wijnholds,et al.  Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. , 2003, Molecular pharmacology.

[15]  D. Keppler,et al.  ATP-Dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4) , 2008, Journal of Pharmacology and Experimental Therapeutics.

[16]  M. Kuwano,et al.  Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. , 2002, Cancer research.

[17]  S. Cole,et al.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. , 2006, Physiological reviews.

[18]  R. Evans,et al.  Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.

[19]  Z. Sauna,et al.  Multidrug Resistance Protein 4 (ABCC4)-mediated ATP Hydrolysis , 2004, Journal of Biological Chemistry.

[20]  D. Keppler,et al.  Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane , 2003, Hepatology.

[21]  H. Kroemer,et al.  The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. , 2004, Blood.

[22]  F. Russel,et al.  Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  H. Glaeser,et al.  Variability in human hepatic MRP4 expression: influence of cholestasis and genotype , 2008, The Pharmacogenomics Journal.

[24]  F. Russel,et al.  Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. , 2005, American journal of physiology. Renal physiology.

[25]  Y. Kanai,et al.  New insights into renal transport of urate , 2007, Current opinion in rheumatology.

[26]  Nathalie Ulryck,et al.  Structure of the human multidrug resistance protein 1 nucleotide binding domain 1 bound to Mg2+/ATP reveals a non-productive catalytic site. , 2006, Journal of molecular biology.

[27]  F. Russel,et al.  Molecular aspects of renal anionic drug transport. , 2002, Annual review of physiology.

[28]  A. Klein-Szanto,et al.  Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. , 2007, Cancer research.

[29]  Jeffrey S Moffit,et al.  Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.

[30]  H. Endou,et al.  Human vascular smooth muscle cells express a urate transporter. , 2006, Journal of the American Society of Nephrology : JASN.

[31]  P. Wielinga,et al.  Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro , 2005, Molecular Cancer Therapeutics.

[32]  Piet Borst,et al.  cGMP transport by vesicles from human and mouse erythrocytes , 2007, The FEBS journal.

[33]  F. Russel,et al.  ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. , 2006, Kidney international.

[34]  H. Kroemer,et al.  Cellular Export of Drugs and Signaling Molecules by the ATP-binding Cassette Transporters MRP4 (ABCC4) and MRP5 (ABCC5) , 2005, Drug metabolism reviews.

[35]  Y. Tanaka,et al.  Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. , 2006, Biochemical pharmacology.

[36]  F. Russel,et al.  The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. , 2002, Journal of the American Society of Nephrology : JASN.

[37]  J. Boyer,et al.  Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. , 2004, Journal of hepatology.

[38]  H. Meurs,et al.  Extracellular matrix proteins differentially regulate airway smooth muscle phenotype and function. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[39]  C. Klaassen,et al.  Up-regulation of Mrp4 expression in kidney of Mrp2-deficient TR- rats. , 2005, Biochemical pharmacology.

[40]  F. Russel,et al.  Interaction of Nonsteroidal Anti-Inflammatory Drugs with Multidrug Resistance Protein (MRP) 2/ABCC2- and MRP4/ABCC4-Mediated Methotrexate Transport , 2007, Journal of Pharmacology and Experimental Therapeutics.

[41]  C. Cai,et al.  Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells , 2007, Prostate Cancer and Prostatic Diseases.

[42]  J. Schuetz,et al.  MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs , 1999, Nature Medicine.

[43]  K. Zatloukal,et al.  Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[44]  S. Hladky,et al.  Modulatory effects of plant phenols on human multidrug‐resistance proteins 1, 4 and 5 (ABCC1, 4 and 5) , 2005, The FEBS journal.

[45]  T. Terasaki,et al.  Multichannel Liquid Chromatography–Tandem Mass Spectrometry Cocktail Method for Comprehensive Substrate Characterization of Multidrug Resistance-Associated Protein 4 Transporter , 2007, Pharmaceutical Research.

[46]  J. Boyer,et al.  Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.

[47]  Peijin Zhang,et al.  CHARACTERIZATION OF TRANSPORT PROTEIN EXPRESSION IN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) 2-DEFICIENT RATS , 2006, Drug Metabolism and Disposition.

[48]  K. Robinson,et al.  Mechanism of Active Renal Tubular Efflux of Tenofovir , 2006, Antimicrobial Agents and Chemotherapy.

[49]  Yuichi Sugiyama,et al.  Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. , 2007, Journal of the American Society of Nephrology : JASN.

[50]  S. Waxman,et al.  Disruption of cAMP and Prostaglandin E2 Transport by Multidrug Resistance Protein 4 Deficiency Alters cAMP-Mediated Signaling and Nociceptive Response , 2007, Molecular Pharmacology.

[51]  C. Klaassen,et al.  Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. , 2008, Toxicology and applied pharmacology.

[52]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[53]  P. Borst,et al.  Multidrug resistance-associated proteins 3, 4, and 5 , 2007, Pflügers Archiv - European Journal of Physiology.

[54]  J. Schellens,et al.  Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[55]  M. Zaccolo,et al.  Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia , 2007, Cell.

[56]  K. Sakamoto,et al.  Expression of multidrug resistance protein 4 and 5 in the porcine coronary and pulmonary arteries. , 2003, European journal of pharmacology.

[57]  Kazuya Maeda,et al.  Multiple Human Isoforms of Drug Transporters Contribute to the Hepatic and Renal Transport of Olmesartan, a Selective Antagonist of the Angiotensin II AT1-Receptor , 2007, Drug Metabolism and Disposition.

[58]  D. Keppler,et al.  Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[59]  Daxi Sun,et al.  Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. , 2007, Cancer research.

[60]  Zhe-Sheng Chen,et al.  Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. , 2001, The Journal of biological chemistry.

[61]  Konstantinos Lefkimmiatis,et al.  Extracellular calcium and cAMP: second messengers as "third messengers"? , 2007, Physiology.

[62]  T. Ogihara,et al.  Involvement of Uric Acid Transporters in Alteration of Serum Uric Acid Level by Angiotensin II Receptor Blockers , 2008, Pharmaceutical Research.

[63]  Yuichi Sugiyama,et al.  Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.